用户名: 密码: 验证码:
牛口蹄疫病毒VP2-ELISA和3B表位串联肽间接ELISA试剂盒的研制
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
口蹄疫(Foot and Mouth Disease, FMD)是由口蹄疫病毒(Foot-and-mouth disease virus, FMDV)引起的以感染偶蹄动物为主的急性、热性、高度传染性疫病。该病的发生和流行严重危害畜牧业的健康持续发展,造成巨大的经济损失,该病被世界动物卫生组织列为必须通报的多种动物共患传染病之一。从2005年起国内不断发生牛口蹄疫,目前面临着Asia 1型口蹄疫的持续危害、O型FMDV的复发感染、新型毒株A型的侵袭风险。因此,国内口蹄疫的防控任务艰巨。我国防控FMD主要采取疫苗免疫和抗体监测为主的综合防控政策,通过接种疫苗提高畜群整体抗体水平来预防口蹄疫的感染和传播。因此牛口蹄疫感染的快速诊断、免疫效果评价、自然感染和疫苗免疫的鉴别诊断成为防控口蹄疫的关键技术。
     本研究通过pPROEXTM HTb表达载体在大肠杆菌DH5α中成功表达了FMDV的vp2基因,获得大小为35ku的融合蛋白,Western blot证实目的蛋白可与FMDV 5种血清型的牛阳性血清发生特异性反应。以此纯化蛋白为抗原建立了牛FMDV VP2蛋白间接ELISA方法。特异性试验表明,该抗原不与常见的7种牛病阳性血清发生交叉反应。检测非免疫无口蹄疫地区牛阴性血清特异性为100%;检测感染血清敏感性为97.3%;与4种商品化试剂盒比较检测O-Asia 1二价灭活苗免疫牛血清364份,符合率分别为69.0%、95.0%、90.4%和86.8%。试验结果表明建立的ELISA方法可用于牛口蹄疫感染和免疫抗体检测。
     本研究利用实验室融合表达的3B表位串联肽(8BF)为检测抗原建立的间接ELISA为基础,优化组装了一种特异、敏感的间接ELISA试剂盒。通过检测大量未免疫、免疫健康牛血清和感染牛血清,确定了判定标准:S/P≥0.3,阳性;0.2≤S/P<0.3,可疑;S/P<0.2,阴性。8BF-ELISA试剂盒检测NSP抗体持续期试验表明,自然感染牛3B表位肽感染后10个月仍为阳性。与3种商品化试剂盒比较检测101份临床样本,和Ceditest? FMDV-NS ELISA、3ABC-I-ELISA符合率高达95%;与3ABC-I-ELISA进一步比较检测528份不同背景的牛血清,总符合率为94.5%(499/528)。大规模检测不同来源的6个牛场共2026份临床牛血清,部分牛群全部阴性,大多数牛群含有阳性牛,阳性率从3%到17%不等,个别感染牛群阳性率高达72.2%。8BF-ELISA试剂盒方便、安全、实用,特异性和敏感性高,用于鉴别诊断牛FMD自然感染和疫苗免疫,为FMD综合防控提供了技术支持。
Foot-and-mouth disease (FMD) caused by foot-and-mout disease virus (FMDV) is a highly contagious and acutely infected disease of cattle, pigs, sheep, goats and wild ruminant species. It has an economically devastating impact on affected countries, where it creates great losses to productivity and considerable economic losses to the husbandry industry. Whenever the disease has happened; it is must reported to the OIE. Since the Asia 1 FMDV first reported in 2005 in china, there are several outbreaks with the Asia 1, O and A serotypes. There is a complex policy to control the FMD mainly by the preventive vaccination in china, where the most animals are vaccinated 2-4 times every year. So the accurate and in-time diagnosis and routine surveillance become very important for the disease control. Thus, diagnostic methods play an important role for FMD control.
     The complete gene encoding the structural protein VP2 of FMDV was subcloned into expression vector pPROEXTM HTb and expressed in DH5αcells. Purified VP2 protein reacted positively with serotype-specific cattle sera of 5 serotypes of FMDV (O, A, C, SAT 2 and Asia 1) by western blot. An indirect ELISA (VP2-ELISA) was developed using purified protein to detect FMDV antibodies in cattles. The protein had no cross-reaction with the positive sera of other bovine diseases. The specificity was 100% to detect the negative cattle serum from Canada where was free of FMD without vaccination. The sensitivity was 97.3% to detect infected sera. Comparison with four commercial kit showed a coincidence rate of 69.0%、95.0%、90.4% and 86.8% against vaccinated cattle serum, respectively. Thus the VP2-ELISA can be used to detect the infected and vaccinated cattle serum.
     To differentiate antibodies induced by FMDV infection from those induced by vaccination, an indirect ELISA was established then the kit was developed, using purified tandem epitopes of 3B protein as antigen. A large number of sera from naive, vaccinated and infected cattle were examined for determination of the cut-off value of the method. The cut-off value was established as follows: positive, S/P≥0.3; suspicious, 0.2≤value<0.3; negative, S/P <0.2. Seroreactivity to 8BF in some infected cattle was maintained through 10 months. The rate of agreement with Ceditest? FMDV-NS ELISA and the 3ABC-I-ELISA was up of 95% by detection of 101 field cattle serum. The performance of this assay was further validated by 3ABC-I-ELISA kits. The coincident rate was 94.5% (499/528), respectively. The number of 2026 cattle sera derived from with different situations (na?ve, unknown, immune and infectious status) were detected. The prevalence of 8BF antibodies reached 72.2% in some diseased cattle herds. The described 8BF-ELISA is safe, cheap and also easy to perform in large scale of serological surveys. The high specificity and sensitivity makes this test a good tool for better distinguishing between infected and vaccinated cattle.
引文
曹轶梅,卢曾军,刘在新,等.2005.用大肠杆菌表达FMDV NSP 3ABC鉴别感染与注苗动物ELISA方法的建立[J].畜牧兽医学报.36(4):381-384
    陈波,尤永进,潘洁,等.2007.区分动物疫苗免疫与病毒感染的口蹄疫非结构蛋白3AB鉴别诊断试剂盒的研制[J].中国预防兽医学报.(01):53-56
    龚振华,蒋正军,王若聪,等.2005.3A蛋白间接ELISA试验检测猪口蹄疫感染抗体的研究[J].中国动物检疫.(11):20-23
    胡大利,冯宇,张培因,等.2007.建立一种用重组蛋白检测抗口蹄疫病毒抗体的间接ELISA方法[J]中国免疫学杂志.23(04):345-348
    蒋韬,梁仲,陈涓,等.2007.检测Asia 1型口蹄疫病毒的胶体金免疫层析法的建立及应用[J]细胞与分子免疫学杂志.23(11):1021-1024
    蒋韬,梁仲,陈涓,等.2008.O型口蹄疫病毒免疫层析试纸条检测方法的建立[J]畜牧兽医学报.39(1):60-65
    蒋韬,梁仲,陈涓,等.2008.口蹄疫病毒O、A、Asia 1型定型诊断胶体金免疫层析方法的建立[J].中国农业科学.41(11):3801-3808
    林彤,邵军军,丛国正,等.2009.Asia1型口蹄疫病毒胶体金免疫层析检测方法的建立[J].生物工程学报.25(5):767-772
    卢永干.1998.1997年台湾省口蹄疫流行概况[J].中国兽医科技.(05).21-23
    鲁会军,金宁一,郑敏,等.2009.Asia1型口蹄疫病毒多表位基因的原核表达及ELISA检测方法的建立[J].中国兽医科学.(01):88-92
    潘洁,陈波,邢继兰,等.2006.口蹄疫病毒3AB试剂盒的检测及比较[J].上海农业学报.22(2): 20-23
    曲哲会,王君伟,郭晓秋,等.2007.口蹄疫病毒vp2基因的原核表达及抗原性检测[J].中国预防兽医学报.29(2): 91-95
    王传彬,王宏伟,孙明,等.2005.口蹄疫病毒3A、3B、3C基因克隆、表达及其抗体消长规律的研究[J].中国农业科学.(10):1264-1070
    王宏伟,孙明,田克恭,等.2004.口蹄疫病毒3ABC、3AB、3BC基因克隆、表达及其抗体消长规律的研究[J].中国农业科学.37(7):1065-1070
    向敏,张克山,卢顺,等.2008.Asia 1口蹄疫Vp2蛋白单克隆抗体的制备及单抗竞争ELISA方法的建立[J].生物工程学报.24(9): 1664-1669
    谢庆阁. 2004.口蹄疫[M].北京:中国农业出版社:1-2
    杨苏珍,杨继飞,鲍登克,等.2009.以合成肽为抗原检测O型口蹄疫病毒抗体ELISA方法的建立和评价[J].畜牧兽医学报.40(12):1826-1830.
    张长弓,金颜辉,黄印尧,等.2004.口蹄疫抗体免疫金标快速检测试纸法的建立[J].福建畜牧兽医.26(1):4-5
    张喜悦,徐天刚,刘春菊,等.2009.免疫层析试纸条检测口蹄疫非结构蛋白3ABC抗体的研究[J].中国预防兽医学报.(07):532-535
    朱彩珠,张强,常惠芸,等.2003.NSP-ELISA鉴别FMDV感染与免疫[J].中国兽医科技. 33(8):3-6
    祝秀梅,卢曾军,胡永浩,等.2008.检测猪血清口蹄疫病毒非结构蛋白3AB抗体ELISA方法的建立[J].甘肃农业大学学报(01):16-20
    Aldabe R, Irurzun A, Carrasco L. 1997.Poliovirus Protein 2BC Increases Cytosolic Free Calcium Concentrations[J].J Virol,71(8):6214-6217.
    Alexandersen S, Zhang Z, Donaldson AI, et al. 2003.The Pathogenesis and Diagnosis of Foot-and-Mouth Disease[J].J Comp Pathol.129(1):1-36.
    Bachrach HL, Morgan DO, Moore DM. 1979.Foot-and-Mouth Disease Virus Immunogenic Capsid Protein VPT: N-Terminal Sequences and Immunogenic Peptides Obtained by CNBI and Tryptic Cleavages[J].Intervirology.12(2):65-72.
    Bahnemann HG. 1990.Inactivation of Viral Antigens for Vaccine Preparation with Particular Reference to the Application of Binary Ethylenimine[J].Vaccine. 8(4):299-303.
    Belsham GJ. 1993.Distinctive Features of Foot-and-Mouth Disease Virus, a Member of the Picornavirus Family; Aspects of Virus Protein Synthesis, Protein Processing and Structure[J].Prog Biophys Mol Biol. 60(3):241-260.
    Berger HG, Straub OC, Ahl R, et al. 1990.Identification of Foot-and-Mouth Disease Virus Replication in Vaccinated Cattle by Antibodies to NonStructural Virus Proteins[J]. Vaccine. 8(3):213-216.
    Bergmann IE, Astudillo V, Malirat V, et al. 1998.Serodiagnostic Strategy for Estimation of Foot-and-Mouth Disease Viral Activity through Highly Sensitive Immunoassays Using Bioengineered Nonstructural Proteins[J].Vet Q.20 Suppl 2:S6-S9.
    Bergmann IE, de Mello PA, Neitzert E, et al. 1993.Diagnosis of Persistent Aphthovirus Infection and its Differentiation From Vaccination Response in Cattle by Use of Enzyme-Linked Immunoelectrotransfer Blot Analysis with Bioengineered Nonstructural Viral Antigens[J].Am J Vet Res.54(6):825-831.
    Bergmann IE, Malirat V, Neitzert E, et al. 2000.Improvement of a Serodiagnostic Strategy for Foot-and-Mouth Disease Virus Surveillance in Cattle Under Systematic Vaccination: A Combined System of an Indirect Elisa-3ABC with an Enzyme-Linked Immunoelectrotransfer Blot Assay[J].Arch Virol.145(3):473-489.
    Bergmann IE, Malirat V, Neitzert E. 2005.Non-Capsid Proteins to Identify Foot-and-Mouth Disease Viral Circulation in Cattle Irrespective of Vaccination[J].Biologicals.33(4):235-239.
    Bergmann IE, Neitzert E, Malirat V, et al. 2003.Rapid Serological Profiling by Enzyme-Linked Immunosorbent Assay and its Use as an Epidemiological Indicator of Foot–and -Mouth Disease Viral Activity[J].Arch Virol.148(5):891-901.
    Brocchi E, Bergmann IE, Dekker A, et al. 2006.Comparative Evaluation of Six ELISAs for the Detection of Antibodies to the Non-Structural Proteins of Foot-and-Mouth Disease Virus [J]. Vaccine. 24(47-48):6966-6979.
    Brooksby JB. 1982.Portraits of Viruses: Foot-and-Mouth Disease Virus [J]. Intervirology. 18 (1-2):1-23.
    Callahan JD, Brown F, Osorio FA, et al. 2002.Use of a Portable Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay for Rapid Detection of Foot-and-Mouth Disease Virus[J].J Am Vet Med Assoc.220(11):1636-1642.
    Callens M, De Clercq K. 1997.Differentiation of the Seven Serotypes of Foot-and-Mouth Disease Virus by Reverse Transcriptase Polymerase Chain Reaction[J].J Virol Methods. 67 (1): 35-44.
    Campos RM, Malirat V, Neitzert E, et al. 2008.Development and Characterization of a Bovine Serum Evaluation Panel as a Standard for Immunoassays Based On Detection of Antibodies Against Foot-and-Mouth Disease Viral Non-Capsid Proteins[J].J Virol Methods. 151 (1): 15-23.
    Chen SP, Ellis TM, Lee MC, et al. 2007.Comparison of Sensitivity and Specificity in Three Commercial Foot-and-Mouth Disease Virus Non-Structural Protein ELISA Kits with Swine Sera in Taiwan[J].Vet Microbiol.119(2-4):164-172.
    Chenard G, Miedema K, Moonen P, et al. 2003.A Solid-Phase Blocking ELISA for Detection of Type O Foot-and-Mouth Disease Virus Antibodies Suitable for Mass Serology[J].J Virol Methods. 107(1):89-98.
    Choe SS, Dodd DA, Kirkegaard K. 2005.Inhibition of Cellular Protein Secretion by Picornaviral 3AProteins[J].Virology.337(1):18-29.
    Chung WB, Sorensen KJ, Liao PC, et al. 2002.Differentiation of Foot-and-Mouth Disease Virus-Infected From Vaccinated Pigs by Enzyme-Linked Immunosorbent Assay Using Nonstructural Protein 3AB as the Antigen and Application to an Eradication Program[J].J Clin Microbiol.40(8):2843-2848.
    Clavijo A, Wright P, Kitching P. 2004.Developments in Diagnostic Techniques for Differentiating Infection From Vaccination in Foot-and-Mouth Disease[J].Vet J.167(1):9-22.
    Cooke JN, Westover KM. 2008.Serotype-Specific Differences in Antigenic Regions of Foot-and-Mouth Disease Virus (FMDV): A Comprehensive Statistical Analysis[J].Infect Genet Evol.8(6):855-863.
    Cowan KM, Graves JH. 1966. A Third Antigenic Component Associated with Foot-and-Mouth Disease Infection[J].Virology.30(3):528-540.
    Cox SJ, Voyce C, Parida S, et al. 2005.Protection Against Direct-Contact Challenge Following Emergency Fmd Vaccination of Cattle and the Effect On Virus Excretion From the Oropharynx[J].Vaccine.23(9):1106-1113.
    Crowther JR, Farias S, Carpenter WC, et al. 1993.Identification of a Fifth Neutralizable Site On Type O Foot-and-Mouth Disease Virus Following Characterization of Single and Quintuple Monoclonal Antibody Escape Mutants[J].J Gen Virol.74 ( Pt 8):1547-1553.
    Curry S, Fry E, Blakemore W, et al. 1997.Dissecting the Roles of Vp0 Cleavage and Rna Packaging in Picornavirus Capsid Stabilization: The Structure of Empty Capsids of Foot-and-Mouth Disease Virus[J].J Virol.71(12):9743-9752.
    De Diego M, Brocchi E, Mackay D, et al. 1997.The Non-Structural Polyprotein 3ABC of Foot-and-Mouth Disease Virus as a Diagnostic Antigen in ELISA to Differentiate Infected From Vaccinated Cattle[J].Arch Virol.142(10):2021-2033.
    Dekker A, Sammin D, Greiner M, et al. 2008.Use of Continuous Results to Compare Elisas for the Detection of Antibodies to Non-Structural Proteins of Foot-and-Mouth Disease Virus [J].Vaccine.26(22):2723-2732.
    Devaney MA, Vakharia VN, Lloyd RE, et al. 1988.Leader Protein of Foot-and-Mouth Disease Virus is Required for Cleavage of the P220 Component of the Cap-Binding Protein Complex[J].J Virol.62(11):4407-4409.
    Domingo E, Mateu MG, Escarmis C, et al. 1996.Molecular Evolution of Aphthoviruses [J]. Virus Genes.11(2-3):197-207.
    Donnelly ML, Gani D, Flint M, et al. 1997.The Cleavage Activities of Aphthovirus and Cardiovirus 2A Proteins[J].J Gen Virol.78 ( Pt 1):13-21.
    Donnelly ML, Luke G, Mehrotra A, et al. 2001.Analysis of the Aphthovirus 2A/2B Polyprotein 'Cleavage' Mechanism Indicates Not a Proteolytic Reaction, but a Novel Translational Effect: A Putative Ribosomal 'Skip'[J].J Gen Virol.82(Pt 5):1013-1025.
    Ferris NP, Nordengrahn A, Hutchings GH, et al. 2009.Development and Laboratory Validation of a Lateral Flow Device for the Detection of Foot-and-Mouth Disease Virus in Clinical Samples[J].J Virol Methods.155(1):10-17.
    Foord AJ, Muller JD, Yu M, et al. 2007.Production and Application of Recombinant Antibodies to Foot-and-Mouth Disease Virus Non-Structural Protein 3ABC[J].J Immunol Methods.321(1-2):142-151.
    Foster M, Cook A, Cedillo L, et al. 1998.Serological and Cellular Immune Responses to Non-Structural Proteins in Animals Infected with Fmdv[J].Vet Q.20 Suppl 2:S28-S30.
    Freiberg B, Hohlich B, Haas B, et al. 2001.Type-Independent Detection of Foot-and-Mouth Disease Virus by Monoclonal Antibodies that Bind to Amino-Terminal Residues of Capsid Protein VP2 [J].J Virol Methods.92(2):199-205.
    Fukai K, Morioka K, Ohashi S, et al. 2008.Differentiation of Foot-and-Mouth Disease Virus-Infected Pigs From Vaccinated Pigs Using a Western Blotting Assay Based On Baculovirus-Expressed Nonstructural Proteins 2C and 3D[J].J Vet Med Sci.70(12):1353-1357.
    Garcia-Briones M, Rosas MF, Gonzalez-Magaldi M, et al. 2006.Differential Distribution of NonStructural Proteins of Foot-and-Mouth Disease Virus in BHK-21 Cells [J]. Virology.349(2):409-421.
    George M, Venkataramanan R, Gurumurthy CB, et al. 2001.The Non-Structural Leader Protein Gene of Foot-and-Mouth Disease Virus is Highly Variable Between Serotypes[J].Virus Genes.22(3):271-278.
    Goris N, Praet N, Sammin D, et al. 2007.Foot-and-Mouth Disease Non-Structural Protein
    Serology in Cattle: Use of a Bayesian Framework to Estimate Diagnostic Sensitivity and Specificity of Six Elisa Tests and True Prevalence in the Field[J].Vaccine.25(41):7177-7196.
    Gradi A, Foeger N, Strong R, et al. 2004.Cleavage of Eukaryotic Translation Initiation Factor 4Gii within Foot-and-Mouth Disease Virus-Infected Cells: Identification of the L-Protease Cleavage Site in Vitro[J].J Virol.78(7):3271-3278.
    Grigera PR, Tisminetzky SG, Lebendiker MB, et al. 1988.Presence of a 43-Kda Host-Cell Polypeptide in Purified Aphthovirions[J].Virology.165(2):584-588.
    Hamblin C, Barnett IT, Crowther JR. 1986.A New Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Antibodies Against Foot-and-Mouth DiseaseVirus.Ii. Application [J].J Immunol Methods.93(1):123-129.
    Hamblin C, Barnett IT, Hedger RS. 1986.A New Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Antibodies Against Foot-and-Mouth Disease Virus. I. Development and Method of Elisa[J].J Immunol Methods.93(1):115-121.
    Hedger RS, Condy JB, Golding SM. 1972.Infection of some Species of African Wild Life with Foot-and-Mouth Disease Virus[J].J Comp Pathol.82(4):455-461.
    Hohlich BJ, Wiesmuller KH, Schlapp T, et al. 2003.Identification of Foot-and-Mouth Disease Virus-Specific Linear B-Cell Epitopes to Differentiate Between Infected and Vaccinated Cattle[J].J Virol.77(16):8633-8639.
    Inoue T, Parida S, Paton DJ, et al. 2006.Development and Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay for Detection of Foot-and-Mouth Disease Virus Nonstructural Protein Antibody Using a Chemically Synthesized 2B Peptide as Antigen[J].J Vet Diagn Invest.18(6):545-552.
    Kitson JD, McCahon D, Belsham GJ. 1990.Sequence Analysis of Monoclonal Antibody Resistant Mutants of Type O Foot and Mouth Disease Virus: Evidence for the Involvement of the Three Surface Exposed Capsid Proteins in Four Antigenic Sites[J].Virology.179(1):26-34.
    Ko YJ, Jeoung HY, Lee HS, et al. 2009.A Recombinant Protein-Based Elisa for Detecting Antibodies to Foot-and-Mouth Disease Virus Serotype Asia 1[J].J Virol Methods.159(1):112-118.
    Kumar N, Sharma R, Kakker NK. 2007.Non-Structural Protein 3a for Differentiation of Foot-and-Mouth Disease Infected and Vaccinated Animals in Haryana (India)[J].Zoonoses Public Health.54(9-10):376-382.
    Lea S, Abu-Ghazaleh R, Blakemore W, et al. 1995.Structural Comparison of Two Strains of Foot-and-Mouth Disease Virus Subtype O1 and a Laboratory Antigenic Variant, G67[J]. Structure.3(6):571-580.
    Lea S, Hernandez J, Blakemore W, et al. 1994.The Structure and Antigenicity of a Type C Foot-and-Mouth Disease Virus[J].Structure.2(2):123-139.
    Lee F, Jong MH, Yang DW. 2006.Presence of Antibodies to Non-Structural Proteins of Foot-and-Mouth Disease Virus in Repeatedly Vaccinated Cattle[J].Vet Microbiol.115(1-3):14-20.
    Lu Z, Cao Y, Guo J, et al. 2007.Development and Validation of a 3ABC Indirect Elisa forDifferentiation of Foot-and-Mouth Disease Virus Infected From Vaccinated Animals[J].Vet Microbiol.125(1-2):157-169.
    Lubroth J, Brown F. 1995.Identification of Native Foot-and-Mouth Disease Virus Non-Structural Protein 2C as a Serological Indicator to Differentiate Infected From Vaccinated Livestock[J].Res Vet Sci.59(1):70-78.
    Lubroth J, Grubman MJ, Burrage TG, et al. 1996.Absence of Protein 2C From Clarified Foot-and-Mouth Disease Virus Vaccines Provides the Basis for Distinguishing Convalescent From Vaccinated Animals[J].Vaccine.14(5):419-427.
    Mackay DK, Bulut AN, Rendle T, et al. 2001.A Solid-Phase Competition Elisa for Measuring Antibody to Foot-and-Mouth Disease Virus[J].J Virol Methods.97(1-2):33-48.
    Mackay DK, Forsyth MA, Davies PR, et al. 1998.Antibody to the Nonstructural Proteins of Foot-and-Mouth Disease Virus in Vaccinated Animals Exposed to Infection[J].Vet Q,20 Suppl 2:S9-S11.
    Mackay DK, Forsyth MA, Davies PR, et al. 1998.Differentiating Infection From Vaccination in Foot-and-Mouth Disease Using a Panel of Recombinant, Non-Structural Proteins in Elisa[J].Vaccine.16(5):446-459.
    Malirat V, Neitzert E, Bergmann IE, et al. 1998.Detection of Cattle Exposed to Foot-and-Mouth Disease Virus by Means of an Indirect Elisa Test Using Bioengineered Nonstructural Polyprotein 3ABC[J].Vet Q,20 Suppl 2:S24-S26.
    Mateu MG. 1995.Antibody Recognition of Picornaviruses and Escape From Neutralization: A Structural View[J].Virus Res.38(1):1-24.
    Moonen P, Jacobs L, Crienen A, et al. 2004.Detection of Carriers of Foot-and-Mouth Disease Virus Among Vaccinated Cattle[J].Vet Microbiol.103(3-4):151-160.
    Moonen P, van der Linde E, Chenard G, et al. 2004.Comparable Sensitivity and Specificity in Three Commercially Available Elisas to Differentiate Between Cattle Infected with or Vaccinated Against Foot-and-Mouth Disease Virus[J].Vet Microbiol.99(2):93-101.
    Muller JD, McEachern JA, Bossart KN, et al. 2008.Serotype-Independent Detection of Foot-and-Mouth Disease Virus[J].J Virol Methods.151(1):146-153.
    Muller JD, Wilkins M, Foord AJ, et al. 2009.Improvement of a Recombinant Antibody-Based Serological Assay for Foot-and-Mouth Disease Virus[J].J Immunol Methods. 141(1):143-150.
    Nayak A, Goodfellow IG, Belsham GJ. 2005.Factors Required for the Uridylylation of the Foot-and-Mouth Disease Virus 3B1, 3B2, and 3B3 Peptides by the RNA-Dependent RNA Polymerase (3Dpol) in Vitro[J].J Virol.79(12):7698-7706.
    Neitzert E, Beck E, de Mello PA, et al. 1991.Expression of the Aphthovirus Rna Polymerase Gene in Escherichia Coli and its Use Together with Other Bioengineered Nonstructural Antigens in Detection of Late Persistent Infections[J].Virology.184(2):799-804.
    Newman JF, Piatti PG, Gorman BM, et al. 1994.Foot-and-Mouth Disease Virus Particles Contain Replicase Protein 3D[J].Proc Natl Acad Sci U S A.91(2):733-737.Oem JK, Chang BS, Joo HD,et al. 2007.Development of an Epitope- Blocking- Enzyme-
    Linked Immunosorbent Assay to Differentiate Between Animals Infected with and Vaccinated Against Foot-and-Mouth Disease Virus[J].J Virol Methods.142(1-2):174-181.
    Oem JK, Park JH, Lee KN,et al. 2007.Characterization of Recombinant Foot-and-Mouth Disease Virus Pentamer-Like Structures Expressed by Baculovirus and their Use as Diagnostic Antigens in a Blocking Elisa[J].Vaccine.25(20):4112-4121.
    Oem JK, Yeh MT, McKenna TS,et al. 2008.Pathogenic Characteristics of the Korean 2002 Isolate of Foot-and-Mouth Disease Virus Serotype O in Pigs and Cattle[J].J Comp Pathol.138 (4):204-214.
    OIE. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, chapter 2.1.5. Foot and Mouth Disease, http://www.oie.int/eng/normes/mmanual/A_summry.htm. 2009
    Paiba GA, Anderson J, Paton DJ,et al. 2004.Validation of a Foot-and-Mouth Disease Antibody Screening Solid-Phase Competition Elisa (Spce)[J].J Virol Methods.115(2):145-158.
    Parida S, Anderson J, Cox SJ,et al. 2006.Secretory Iga as an Indicator of Oro-Pharyngeal Foot-and-Mouth Disease Virus Replication and as a Tool for Post Vaccination Surveillance[J].Vaccine.24(8):1107-1116.
    Parida S, Fleming L, Gibson D,et al. 2007.Bovine Serum Panel for Evaluating Foot-and-Mouth Disease Virus Nonstructural Protein Antibody Tests[J].J Vet Diagn Invest. 19 (5): 539-544.
    Perkins J, Parida S, Clavijo A. 2007.Use of a Standardized Bovine Serum Panel to Evaluate a Multiplexed Nonstructural Protein Antibody Assay for Serological Surveillance of Foot-and-Mouth Disease [J].Clin Vaccine Immunol.14(11):1472-1482.
    Piccone ME, Rieder E, Mason PW,et al. 1995.The Foot-and-Mouth Disease Virus Leader Proteinase Gene is Not Required for Viral Replication[J].J Virol.69(9):5376-5382.
    Pinto AA, Garland AJ. 1979.Immune Response to Virus-Infection-Associated (VIA) Antigen in Cattle Repeatedly Vaccinated with Foot-and-Mouth Disease Virus Inactivated by Formalin or Acetylethyleneimine[J].J Hyg (Lond).82(1):41-50.
    Plotch SJ, Palant O. 1995.Poliovirus Protein 3Ab Forms a Complex with and Stimulates the Activity of the Viral Rna Polymerase, 3Dpol[J].J Virol.69(11):7169-7179.
    Reid SM, Ferris NP, Hutchings GH,et al. 2001.Diagnosis of Foot-and-Mouth Disease by Real-Time Fluorogenic Pcr Assay[J].Vet Rec.149(20):621-623.
    Reid SM, Forsyth MA, Hutchings GH,et al. 1998.Comparison of Reverse Transcription Polymerase Chain Reaction, Enzyme Linked Immunosorbent Assay and Virus Isolation for the Routine Diagnosis of Foot-and-Mouth Disease[J].J Virol Methods.70(2):213-217.
    Reid SM, Grierson SS, Ferris NP,et al. 2003.Evaluation of Automated RT-PCR to Accelerate the Laboratory Diagnosis of Foot-and-Mouth Disease Virus[J].J Virol Methods.107(2):129-139.
    Saiz JC, Gonzalez MJ, Borca MV,et al. 1991.Identification of Neutralizing Antigenic Sites On VP1 and VP2 of Type A5 Foot-and-Mouth Disease Virus, Defined by Neutralization-ResistantVariants[J].J Virol.65(5):2518-2524.
    Saiz M, Gomez S, Martinez-Salas E,et al. 2001.Deletion Or Substitution of the Aphthovirus 3' NCR Abrogates Infectivity and Virus Replication[J].J Gen Virol.82(Pt 1):93-101.
    Saiz M, Ro YT, Wirth DF,et al. 1999.Host Cell Proteins Bind Specifically to the Capsid-Cleaved 5' End of Leishmaniavirus Rna[J].J Biochem.126(3):538-544.
    Samuel AR, Knowles NJ. 2001.Foot-and-Mouth Disease Type O Viruses Exhibit Genetically and Geographically Distinct Evolutionary Lineages (Topotypes)[J].J Gen Virol.82(Pt 3):609-621.
    Sangar DV, Clark RP, Carroll AR,et al. 1988.Modification of the Leader Protein (Lb) of Foot-and-Mouth Disease Virus[J].J Gen Virol.69 ( Pt 9):2327-2333.
    Shaw AE, Reid SM, Ebert K,et al. 2007.Implementation of a One-Step Real-Time RT-PCR Protocol for Diagnosis of Foot-and-Mouth Disease[J].J Virol Methods.143(1):81-85.
    Shen F, Chen PD, Walfield AM,et al. 1999.Differentiation of Convalescent Animals From those Vaccinated Against Foot-and-Mouth Disease by a Peptide ELISA[J]. Vaccine, 17 (23-24) :3039-3049.
    Sobrino F, Saiz M, Jimenez-Clavero MA,et al. 2001.Foot-and-Mouth Disease Virus: A Long Known Virus, but a Current Threat[J].Vet Res.32(1):1-30.
    Sorensen KJ, de Stricker K, Dyrting KC,et al. 2005.Differentiation of Foot-and-Mouth Disease Virus Infected Animals From Vaccinated Animals Using a Blocking Elisa Based On Baculovirus Expressed Fmdv 3ABC Antigen and a 3ABC Monoclonal Antibody[J].Arch Virol. 150(4):805-814.
    Sorensen KJ, Madsen KG, Madsen ES,et al. 1998.Differentiation of Infection From Vaccination in Foot-and-Mouth Disease by the Detection of Antibodies to the Non-Structural Proteins 3D, 3AB and 3ABC in Elisa Using Antigens Expressed in Baculovirus [J].Arch Virol.143(8):1461-1476.
    Sun T, Lu P, Wang X. 2004.Localization of Infection-Related Epitopes On the Non-Structural Protein 3ABC of Foot-and-Mouth Disease Virus and the Application of Tandem Epitopes [J].J Virol Methods.119(2):79-86.
    Vangrysperre W, De Clercq K. 1996.Rapid and Sensitive Polymerase Chain Reaction Based Detection and Typing of Foot-and-Mouth Disease Virus in Clinical Samples and Cell Culture Isolates, Combined with a Simultaneous Differentiation with Other Genomically and/or Symptomatically Related Viruses[J].Arch Virol.141(2):331-344.
    Wang CY, Chang TY, Walfield AM,et al. 2001.Synthetic Peptide-Based Vaccine and Diagnostic System for Effective Control of Fmd[J].Biologicals.29(3-4):221-228.
    Wang GH, Du JZ, Cong GZ,et al. 2007.[Establishment of Indirect Elisa Diagnose Based On the Vp1 Structural Protein of Foot-and-Mouth Disease Virus (Fmdv) in Pigs][J]Sheng Wu Gong Cheng Xue Bao.23(5):961-966.
    Yang M, Clavijo A, Li M,et al. 2007.Identification of a Major Antibody Binding Epitope in the Non-Structural Protein 3D of Foot-and-Mouth Disease Virus in Cattle and the Development ofa Monoclonal Antibody with Diagnostic Applications[J].J Immunol Methods.321(1-2):174-181.
    Yang M, Clavijo A, Suarez-Banmann R,et al. 2007.Production and Characterization of Two Serotype Independent Monoclonal Antibodies Against Foot-and-Mouth Disease Virus[J].Vet Immunol Immunopathol.115(1-2):126-134.
    Zhang ZD, Kitching RP. 2001.The Localization of Persistent Foot and Mouth Disease Virus in the Epithelial Cells of the Soft Palate and Pharynx[J].J Comp Pathol.124(2-3):89-94.
    Zibert A, Maass G, Strebel K,et al. 1990.Infectious Foot-and-Mouth Disease Virus Derived From a Cloned Full-Length Cdna[J].J Virol.64(6):2467-2473.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700